Similar articles

• Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.

  Hel Z, Nacsa J, Tryniszewska E, Tsai WP, Parks RW, Montefiori DC, Felber BK, Tartaglia J, Pavlakis GN, Franchini G. Hel Z, et al. J Immunol. 2002 Nov 1;169(9):4778-87. doi: 10.4049/jimmunol.169.9.4778. J Immunol. 2002. PMID: 12391187
• Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.

  McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ. McKenna PM, et al. J Infect Dis. 2007 Apr 1;195(7):980-8. doi: 10.1086/512243. Epub 2007 Feb 20. J Infect Dis. 2007. PMID: 17330788
• A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.

  Malkevitch N, Patterson LJ, Aldrich K, Richardson E, Alvord WG, Robert-Guroff M. Malkevitch N, et al. J Immunol. 2003 Apr 15;170(8):4281-9. doi: 10.4049/jimmunol.170.8.4281. J Immunol. 2003. PMID: 12682263
• Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein.

  Kano M, Matano T, Nakamura H, Takeda A, Kato A, Ariyoshi K, Mori K, Sata T, Nagai Y. Kano M, et al. AIDS. 2000 Jun 16;14(9):1281-2. doi: 10.1097/00002030-200006160-00030. AIDS. 2000. PMID: 10894297 No abstract available.
• Recombinant subunit vaccines against primate lentiviruses.

  Hu SL. Hu SL. AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):451-3. doi: 10.1089/aid.1996.12.451. AIDS Res Hum Retroviruses. 1996. PMID: 8882332 Review. No abstract available.